+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Pap Smear"

From
From
USA & Canada Cervical Cancer Diagnostic Market, Patients by Test Type (Pap Smear, HPV DNA), in North America - Product Thumbnail Image

USA & Canada Cervical Cancer Diagnostic Market, Patients by Test Type (Pap Smear, HPV DNA), in North America

  • Report
  • July 2018
  • 67 Pages
  • Canada, North America Canada, North America
From
From
From
From
From
Loading Indicator

The Pap Smear is a diagnostic test used to detect abnormal cells in the cervix, which can be an early sign of cervical cancer. It is a simple procedure that involves collecting cells from the cervix and examining them under a microscope. The Pap Smear market is a subset of the larger Diagnostics market, which includes a variety of tests used to diagnose and monitor diseases. The Pap Smear market is driven by the need for early detection of cervical cancer, as well as the increasing prevalence of cervical cancer in many countries. The Pap Smear market is highly competitive, with a number of companies offering products and services. Some of the major players in the market include Quest Diagnostics, LabCorp, Hologic, and Roche Diagnostics. Other companies in the market include Abbott Laboratories, Becton Dickinson, and Siemens Healthineers. Show Less Read more